News on Domain Pharma Corporation from BioPortfolio.com http://www.BioPortfolio.com Consolidated Domain Pharma Corporation news from BioPortfolio.com Tue, 09 Feb 2010 21:46:25 GMT en Alfresa Pharma Corporation-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037794&HITNO=0&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037794&THISHREF=http://c.moreover.com/click/here.pl%3fz2537286782%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037794&HITNO=0&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037794&THISHREF=http://c.moreover.com/click/here.pl%3fz2537286782%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Fujifilm Makes a Full-scale Entry into Clinical Development and Pharmaceutical Marketinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034308&HITNO=1&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034308&THISHREF=http://c.moreover.com/click/here.pl%3fz2535708102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034308&HITNO=1&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034308&THISHREF=http://c.moreover.com/click/here.pl%3fz2535708102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAsahi.com: Choongwae Pharma Corporation-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033720&HITNO=2&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033720&THISHREF=http://c.moreover.com/click/here.pl%3fz2535353427%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033720&HITNO=2&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033720&THISHREF=http://c.moreover.com/click/here.pl%3fz2535353427%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Oxford Finance Closes $25 Million Facility With EUSA Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031873&HITNO=3&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031873&THISHREF=http://c.moreover.com/click/here.pl%3fz2534404765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031873&HITNO=3&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031873&THISHREF=http://c.moreover.com/click/here.pl%3fz2534404765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comABF Journal: 'Excise removal can trigger Rs 5k crore pharma investment'http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031053&HITNO=4&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031053&THISHREF=http://c.moreover.com/click/here.pl%3fz2533964056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031053&HITNO=4&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031053&THISHREF=http://c.moreover.com/click/here.pl%3fz2533964056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Standard India: Mitsubishi Tanabe Pharma Corporation-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027238&HITNO=5&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027238&THISHREF=http://c.moreover.com/click/here.pl%3fz2531969926%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027238&HITNO=5&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027238&THISHREF=http://c.moreover.com/click/here.pl%3fz2531969926%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: ISCO stem cell production site passes building inspectionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029322&HITNO=6&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029322&THISHREF=http://c.moreover.com/click/here.pl%3fz2533088894%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029322&HITNO=6&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029322&THISHREF=http://c.moreover.com/click/here.pl%3fz2533088894%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIn-Pharmatechnologist: Finally, working quietly, correctly on drug discoveryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026924&HITNO=7&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026924&THISHREF=http://c.moreover.com/click/here.pl%3fz2531542903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026924&HITNO=7&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026924&THISHREF=http://c.moreover.com/click/here.pl%3fz2531542903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDNA India: Oxford Finance Corporation Closes $25 Million Credit Facility with EUSA Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026073&HITNO=8&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026073&THISHREF=http://c.moreover.com/click/here.pl%3fz2530335150%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026073&HITNO=8&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026073&THISHREF=http://c.moreover.com/click/here.pl%3fz2530335150%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Zacks Analyst Blog Highlights: MasterCard Incorporated, Broadcom Corporation, Allergan, Inc., Medicis Pharma and Johnson & Johnsonhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025271&HITNO=9&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025271&THISHREF=http://c.moreover.com/click/here.pl%3fz2529596524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025271&HITNO=9&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025271&THISHREF=http://c.moreover.com/click/here.pl%3fz2529596524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Zacks Analyst Blog Highlights: MasterCard Incorporated, Broadcom Corporation, Allergan, Inc., Medicis Pharma ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024945&HITNO=10&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024945&THISHREF=http://c.moreover.com/click/here.pl%3fz2529278648%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024945&HITNO=10&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024945&THISHREF=http://c.moreover.com/click/here.pl%3fz2529278648%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: The heart of the deal: A look at notable 09 M&As: M&A activity showed some signs of promise toward the tail end of last year, but the pace was still well below historical norms. That said, 2009 produced a few notable deals. The BBJs Jackie Nobletthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019454&HITNO=11&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019454&THISHREF=http://c.moreover.com/click/here.pl%3fz2526295581%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019454&HITNO=11&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019454&THISHREF=http://c.moreover.com/click/here.pl%3fz2526295581%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Francisco Business Times: Oxford Finance Corporation announces $25M credit facility to EUSA Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019017&HITNO=12&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019017&THISHREF=http://c.moreover.com/click/here.pl%3fz2526066020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019017&HITNO=12&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019017&THISHREF=http://c.moreover.com/click/here.pl%3fz2526066020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Research and Markets: Mitsubishi Tanabe Pharma Corporation - SWOT Analysishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017894&HITNO=13&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017894&THISHREF=http://c.moreover.com/click/here.pl%3fz2525354703%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017894&HITNO=13&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017894&THISHREF=http://c.moreover.com/click/here.pl%3fz2525354703%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Mitsubishi Tanabe Pharma Corporation - SWOT Analysishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017897&HITNO=14&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017897&THISHREF=http://c.moreover.com/click/here.pl%3fz2525355824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017897&HITNO=14&MSIZE=430&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Domain%20Pharma%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017897&THISHREF=http://c.moreover.com/click/here.pl%3fz2525355824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: